Oridonin inhibits gefitinib-resistant lung cancer cells by suppressing EGFR/ERK/MMP-12 and CIP2A/Akt signaling pathways
Xiangling Xiao(Wuhan University), Ying Liu(Hubei University of Medicine)
Cited by 63
Related Papers
ERK and USP5 govern PD-1 homeostasis via deubiquitination to modulate tumor immunotherapy
|Nature Communications|2023|75